Global Cord Blood is a diagnostics & research business based in the US. Global Cord Blood shares (CO) are listed on the NYSE and all prices are listed in US Dollars. Global Cord Blood employs 1,202 staff and has a trailing 12-month revenue of around $1.2 billion.
Finder Award
SoFi Invest
Finder Award
eToro
tastytrade
| Latest market close | $2.99 |
|---|---|
| 52-week range | $2.03 - $4.08 |
| 50-day moving average | $2.99 |
| 200-day moving average | $2.84 |
| Wall St. target price | $15.00 |
| PE ratio | 5.0637 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $0.59 |
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $2.99 from 2023-03-20
| 1 week (2023-03-14) | 2.99 |
|---|---|
| 1 month (2023-02-22) | 2.99 |
| 3 months (2022-12-22) | 2.99 |
| 6 months (2022-09-22) | 34.68% |
| 1 year (2022-03-22) | -24.87% |
|---|---|
| 2 years (2021-03-22) | -36.11% |
| 3 years (2020-03-20) | 3.39 |
| 5 years (2018-03-21) | 11.7528 |
Valuing Global Cord Blood stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Global Cord Blood's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
| Revenue TTM | $1.2 billion |
|---|---|
| Operating margin TTM | 48.97% |
| Gross profit TTM | $1.1 billion |
| Return on assets TTM | 4.63% |
| Return on equity TTM | 10.99% |
| Profit margin | 40.3% |
| Book value | $40.14 |
| Market capitalisation | $400.1 million |
TTM: trailing 12 months
We're not expecting Global Cord Blood to pay a dividend over the next 12 months.
Over the last 12 months, Global Cord Blood's shares have ranged in value from as little as $2.03 up to $4.08. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Global Cord Blood's is -0.0417. This would suggest that Global Cord Blood's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Global Cord Blood has bucked the trend.
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd. .
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
Steps to investing in the Vanguard (VTI) Total Stock Market ETF.
Everything we know about the Neuraxis IPO, plus information on how to buy in.
Everything we know about the TXO Energy IPO, plus information on how to buy in.
Everything we know about the Brera IPO, plus information on how to buy in.
What you need to know about investing in the leading indicator for the overall US stock market.
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
Your simple and straightforward guide to ETFs, how they work and the different types available.
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.